David P. Stonko
Vanderbilt University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David P. Stonko.
Spine | 2016
Scott L. Zuckerman; Silky Chotai; Clinton J. Devin; Scott L. Parker; David P. Stonko; Joseph Wick; Andrew T. Hale; Matthew J. McGirt; Joseph S. Cheng
Study Design. Analysis of prospectively collected longitudinal web-based registry data. Objective. To determine relative validity, responsiveness, and minimum clinically important difference (MCID) thresholds in patients undergoing surgery for intradural extramedullary (IDEM) spinal tumors. Summary of Background Data. Patient-reported outcomes (PROs) are vital in establishing the value of care in spinal pathology. There is limited availability of prospective, quality studies reporting PROs for IDEM spine tumors. Methods. . A total of 40 patients were analyzed. Baseline, postoperative 3-month, and 12-month PROs were recorded: Oswestry Disability Index or Neck disability Index (ODI/NDI), Quality of life EuroQol-5D (EQ-5D), Short Form-12 (SF-12), Numeric Rating Scale (NRS)-pain scores. Responders were defined as those who achieved a level of improvement one or two, after surgery, on health transition index (HTI) of SF-36. Receiver-operating characteristic curves were generated to assess the validity of PROs, and the difference between standardized response means (SRMs) in responders versus nonresponders was utilized to determine the relative responsiveness of each PRO measure. MCID thresholds were derived using previously reported minimal detectable change approach. Results. A significant improvement across all PROs at 3-months and 12-months follow up was noted. The derived MCID thresholds were 13.9 points: ODI/NDI, 0.14 quality adjusted life years: EQ-5D, 2.8 points: SF-12PCS and 10.7 points: SF-12MCS, 1.9 points: NRS-back/neck pain, and 1.8 points: NRS-leg/arm pain. SF-12PCS was most accurate discriminator of meaningful improvement (area under the curve, AUC-0.83) and most responsive (SRM-1.36) to postoperative improvement. EQ-5D, ODI/NDI, NRS-pain scores were all accurate discriminator (AUC-0.7–0.8) and responsive measures (0.97–0.67) of meaningful postoperative improvement. SF-12MCS was neither a valid discriminator (AUC-0.48) nor a responsive measure (SRM: -1.5) of outcome. Conclusion. Surgical resection of IDEM spinal tumors provides significant and sustained improvement in quality of life, general health, disability, and pain at 12-month after surgery. The surgically resected IDEM-specific clinically meaningful thresholds are reported. All the PROs reported in this study can accurately discriminate responders and nonresponder based on SF-36 HTI index except for SF-12 MCS. Level of Evidence: 3
The Spine Journal | 2015
Silky Chotai; J. Alex Sielatycki; Scott L. Parker; Ahilan Sivaganesan; Harrison L. Kay; David P. Stonko; Joseph Wick; Matthew J. McGirt; Clinton J. Devin
BACKGROUND Obese patients have greater comorbidities along with higher risk of complications and greater costs after spine surgery, which may result in increased cost and lower quality of life compared with their non-obese counterparts. PURPOSE The aim of the present study was to determine cost-utility following anterior cervical discectomy and fusion (ACDF) in obese patients. STUDY DESIGN This study analyzed prospectively collected data. PATIENT SAMPLE Patients undergoing elective ACDF for degenerative cervical pathology at a single academic institution were included in the study. OUTCOME MEASURES Cost and quality-adjusted life years (QALYs) were the outcome measures. METHODS One- and two-year medical resource utilization, missed work, and health state values (QALYs) were assessed. Two-year resource use was multiplied by unit costs based on Medicare national payment amounts (direct cost). Patient and caregiver workday losses were multiplied by the self-reported gross-of-tax wage rate (indirect cost). Total cost (direct+indirect) was used to compute cost per QALY gained. Patients were defined as obese for body mass index (BMI) ≥35 based on the WHO definition of class II obesity. A subgroup analysis was conducted in morbidly obese patients (BMI≥40). RESULTS There were significant improvements in pain (neck pain or arm pain), disability (Neck Disability Index), and quality of life (EuroQol-5D and Short Form-12) at 2 years after surgery (p<.001). There was no significant difference in post-discharge health-care resource utilization, direct cost, indirect cost, and total cost between obese and non-obese patients at postoperative 1-year and 2-year follow-up. Mean 2-year direct cost for obese patients was
The Spine Journal | 2015
Elliott J. Kim; Silky Chotai; David P. Stonko; Joseph Wick; Byron J. Schneider; Matthew J. McGirt; Clint Devin
19,225±
Neurosurgery | 2017
Silky Chotai; Scott L. Zuckerman; Scott L. Parker; Joseph Wick; David P. Stonko; Andrew T. Hale; Matthew J. McGirt; Joseph S. Cheng; Clinton J. Devin
8,065 and
Neurosurgery | 2016
John A. Sielatycki; Silky Chotai; Harrison F. Kay; David P. Stonko; Matthew J. McGirt; Clinton J. Devin
17,635±
Neurosurgery | 2018
Elliott J. Kim; Joseph Wick; David P. Stonko; Silky Chotai; Thomas Freeman; Diana Douleh; Akshitkumar M. Mistry; Scott L. Parker; Clinton J. Devin
6,413 for non-obese patients (p=.14). There was no significant difference in the mean total 2-year cost between obese (
Journal of Surgical Education | 2018
David P. Stonko; Dillon C. O′Neill; Bradley M. Dennis; Melissa Smith; Jeffrey Gray; Oscar D. Guillamondegui
23,144±
American Journal of Surgery | 2018
Heather A. Lillemoe; David P. Stonko; Maura E. Sullivan; Sunil K. Geevarghese; Kyla P. Terhune
9,216) and non-obese (
European Spine Journal | 2016
John A. Sielatycki; Silky Chotai; David P. Stonko; Joseph Wick; Harrison F. Kay; Matthew J. McGirt; Clinton J. Devin
22,183±
European Spine Journal | 2016
Harrison F. Kay; Silky Chotai; Joseph Wick; David P. Stonko; Matthew J. McGirt; Clinton J. Devin
10,564) patients (p=.48). Obese patients had a lower mean cumulative gain in QALYs versus non-obese patients at 2-years (0.34 vs. 0.42, p=.32). Two-year cost-utility in obese (